Negative regulation of ERBB signaling pathway

pathway activity — cross-omics
GO:1901185Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of ERBB signaling pathway pathway is significantly associated with the RNA expression of multiple genes, with the PDAC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ERO1A, ALOX5AP, and RAB39B, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of ERBB signaling pathway activity versus ERO1A in PDAC (Pearson r = 0.35).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
PDACERO1A →+0.593+0.184<.001<.00136
LSCCALOX5AP →+0.839+0.274<.001<.00136
HNSCRAB39B →-0.734-0.211<.001<.00135
LSCCIFNGR2 →+0.392+0.218<.001.00835
BRCAS100A10 →+0.764+0.124.008.00526
LUADTNFRSF12A →+0.461+0.149.007<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1901185 vs ERO1A — PDAC

Per-sample scatter of Negative regulation of ERBB signaling pathway activity vs ERO1A in PDAC.

Explore this scatter interactively →

Exploration